US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist
  • 6.395
  • +0.155+2.48%
Trading Mar 28 15:55 ET
1.70BMarket Cap-5329P/E (TTM)

Autolus Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-72.59%1.7M
0
-82.86%406K
0
1.29M
311.02%6.19M
3.83M
2.37M
0
0
Operating revenue
-72.59%1.7M
--0
-82.86%406K
--0
--1.29M
311.02%6.19M
--3.83M
--2.37M
--0
--0
Cost of revenue
Gross profit
Operating expense
18.87%177.23M
173.30%40.89M
4.33%47.85M
2.98%47.86M
-2.77%40.63M
5.08%149.09M
-35.23%14.96M
13.65%45.86M
18.48%46.48M
6.59%41.78M
Selling and administrative expenses
46.54%46.75M
112.20%15.73M
28.92%10.61M
34.50%11.12M
16.24%9.28M
0.11%31.9M
-2.36%7.41M
-0.82%8.23M
14.26%8.27M
-8.59%7.99M
-General and administrative expense
46.54%46.75M
112.20%15.73M
28.92%10.61M
34.50%11.12M
16.24%9.28M
0.11%31.9M
-2.36%7.41M
-0.82%8.23M
14.26%8.27M
-8.59%7.99M
Research and development costs
11.19%130.48M
233.31%25.16M
-1.05%37.24M
-3.85%36.74M
-7.71%31.34M
5.88%117.35M
-51.88%7.55M
16.54%37.63M
18.93%38.21M
10.52%33.96M
Other operating expenses
----
----
----
----
----
79.83%-166K
--0
----
----
38.29%-166K
Operating profit
-22.84%-175.53M
-267.18%-40.89M
-9.08%-47.44M
-2.98%-47.86M
5.86%-39.34M
-1.79%-142.89M
51.79%-11.14M
-7.78%-43.49M
-23.22%-46.48M
-6.59%-41.78M
Net non-operating interest income expense
-338.54%-31.56M
-1,235.20%-27.12M
18.81%-1.37M
6.04%-1.62M
17.20%-1.46M
-753.74%-7.2M
-112.45%-2.03M
-6,117.86%-1.69M
-4,197.62%-1.72M
-4,104.55%-1.76M
Non-operating interest income
690.69%13.51M
111.08%3.01M
2,109.70%3.65M
3,723.60%3.4M
12,207.14%3.45M
551.91%1.71M
857.05%1.43M
489.29%165K
111.90%89K
-36.36%28K
Non-operating interest expense
406.09%45.07M
771.51%30.13M
171.03%5.01M
177.35%5.02M
174.02%4.91M
705.88%8.91M
212.85%3.46M
--1.85M
--1.81M
--1.79M
Other net income (expense)
-186.15%-1.31M
-44.33%3.19M
47.09%-1.98M
134.49%459K
-447.21%-2.99M
285.51%1.52M
6,474.44%5.74M
-493.27%-3.74M
28.02%-1.33M
418.07%860K
Special income (charges)
-710.29%-4.17M
--0
---382K
---23K
---3.77M
23.82%-515K
-12,775.00%-515K
--0
--0
--0
-Less:Impairment of capital assets
--382K
--0
--382K
----
----
--0
--0
--0
----
----
-Gain on sale of property,plant,equipment
-636.12%-3.79M
--0
--0
---23K
---3.77M
23.82%-515K
-12,775.00%-515K
--0
--0
--0
Other non- operating income (expenses)
40.38%2.86M
-48.91%3.19M
57.30%-1.6M
136.21%482K
-9.07%782K
1,505.52%2.04M
7,369.77%6.25M
-493.27%-3.74M
28.02%-1.33M
2.63%860K
Income before tax
-40.27%-208.4M
-772.39%-64.81M
-3.82%-50.79M
1.03%-49.02M
-2.57%-43.78M
-4.60%-148.57M
69.23%-7.43M
-24.24%-48.92M
-25.30%-49.53M
-9.48%-42.69M
Income tax
-106.99%-19K
-36.68%12.36M
19.70%-4.94M
53.57%-3.47M
29.41%-3.97M
368.97%272K
11.40%19.52M
-14.24%-6.15M
-17.57%-7.47M
1.75%-5.62M
Net income
-40.01%-208.38M
-186.34%-77.17M
-7.21%-45.85M
-8.31%-45.55M
-7.42%-39.81M
-4.75%-148.84M
35.32%-26.95M
-25.82%-42.77M
-26.79%-42.06M
-11.41%-37.06M
Net income continuous Operations
-40.01%-208.38M
-186.34%-77.17M
-7.21%-45.85M
-8.31%-45.55M
-7.42%-39.81M
-4.75%-148.84M
35.32%-26.95M
-25.82%-42.77M
-26.79%-42.06M
-11.41%-37.06M
Minority interest income
Net income attributable to the parent company
-40.01%-208.38M
-186.34%-77.17M
-7.21%-45.85M
-8.31%-45.55M
-7.42%-39.81M
-4.75%-148.84M
35.32%-26.95M
-25.82%-42.77M
-26.79%-42.06M
-11.41%-37.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-40.01%-208.38M
-186.34%-77.17M
-7.21%-45.85M
-8.31%-45.55M
-7.42%-39.81M
-4.75%-148.84M
35.32%-26.95M
-25.82%-42.77M
-26.79%-42.06M
-11.41%-37.06M
Basic earnings per share
23.57%-1.2
-95.65%-0.45
44.68%-0.26
43.48%-0.26
43.90%-0.23
20.30%-1.57
54.90%-0.23
0.00%-0.47
2.13%-0.46
22.64%-0.41
Diluted earnings per share
23.57%-1.2
-95.65%-0.45
44.68%-0.26
43.48%-0.26
43.90%-0.23
20.30%-1.57
54.90%-0.23
0.00%-0.47
2.13%-0.46
22.64%-0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -72.59%1.7M0-82.86%406K01.29M311.02%6.19M3.83M2.37M00
Operating revenue -72.59%1.7M--0-82.86%406K--0--1.29M311.02%6.19M--3.83M--2.37M--0--0
Cost of revenue
Gross profit
Operating expense 18.87%177.23M173.30%40.89M4.33%47.85M2.98%47.86M-2.77%40.63M5.08%149.09M-35.23%14.96M13.65%45.86M18.48%46.48M6.59%41.78M
Selling and administrative expenses 46.54%46.75M112.20%15.73M28.92%10.61M34.50%11.12M16.24%9.28M0.11%31.9M-2.36%7.41M-0.82%8.23M14.26%8.27M-8.59%7.99M
-General and administrative expense 46.54%46.75M112.20%15.73M28.92%10.61M34.50%11.12M16.24%9.28M0.11%31.9M-2.36%7.41M-0.82%8.23M14.26%8.27M-8.59%7.99M
Research and development costs 11.19%130.48M233.31%25.16M-1.05%37.24M-3.85%36.74M-7.71%31.34M5.88%117.35M-51.88%7.55M16.54%37.63M18.93%38.21M10.52%33.96M
Other operating expenses --------------------79.83%-166K--0--------38.29%-166K
Operating profit -22.84%-175.53M-267.18%-40.89M-9.08%-47.44M-2.98%-47.86M5.86%-39.34M-1.79%-142.89M51.79%-11.14M-7.78%-43.49M-23.22%-46.48M-6.59%-41.78M
Net non-operating interest income expense -338.54%-31.56M-1,235.20%-27.12M18.81%-1.37M6.04%-1.62M17.20%-1.46M-753.74%-7.2M-112.45%-2.03M-6,117.86%-1.69M-4,197.62%-1.72M-4,104.55%-1.76M
Non-operating interest income 690.69%13.51M111.08%3.01M2,109.70%3.65M3,723.60%3.4M12,207.14%3.45M551.91%1.71M857.05%1.43M489.29%165K111.90%89K-36.36%28K
Non-operating interest expense 406.09%45.07M771.51%30.13M171.03%5.01M177.35%5.02M174.02%4.91M705.88%8.91M212.85%3.46M--1.85M--1.81M--1.79M
Other net income (expense) -186.15%-1.31M-44.33%3.19M47.09%-1.98M134.49%459K-447.21%-2.99M285.51%1.52M6,474.44%5.74M-493.27%-3.74M28.02%-1.33M418.07%860K
Special income (charges) -710.29%-4.17M--0---382K---23K---3.77M23.82%-515K-12,775.00%-515K--0--0--0
-Less:Impairment of capital assets --382K--0--382K----------0--0--0--------
-Gain on sale of property,plant,equipment -636.12%-3.79M--0--0---23K---3.77M23.82%-515K-12,775.00%-515K--0--0--0
Other non- operating income (expenses) 40.38%2.86M-48.91%3.19M57.30%-1.6M136.21%482K-9.07%782K1,505.52%2.04M7,369.77%6.25M-493.27%-3.74M28.02%-1.33M2.63%860K
Income before tax -40.27%-208.4M-772.39%-64.81M-3.82%-50.79M1.03%-49.02M-2.57%-43.78M-4.60%-148.57M69.23%-7.43M-24.24%-48.92M-25.30%-49.53M-9.48%-42.69M
Income tax -106.99%-19K-36.68%12.36M19.70%-4.94M53.57%-3.47M29.41%-3.97M368.97%272K11.40%19.52M-14.24%-6.15M-17.57%-7.47M1.75%-5.62M
Net income -40.01%-208.38M-186.34%-77.17M-7.21%-45.85M-8.31%-45.55M-7.42%-39.81M-4.75%-148.84M35.32%-26.95M-25.82%-42.77M-26.79%-42.06M-11.41%-37.06M
Net income continuous Operations -40.01%-208.38M-186.34%-77.17M-7.21%-45.85M-8.31%-45.55M-7.42%-39.81M-4.75%-148.84M35.32%-26.95M-25.82%-42.77M-26.79%-42.06M-11.41%-37.06M
Minority interest income
Net income attributable to the parent company -40.01%-208.38M-186.34%-77.17M-7.21%-45.85M-8.31%-45.55M-7.42%-39.81M-4.75%-148.84M35.32%-26.95M-25.82%-42.77M-26.79%-42.06M-11.41%-37.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -40.01%-208.38M-186.34%-77.17M-7.21%-45.85M-8.31%-45.55M-7.42%-39.81M-4.75%-148.84M35.32%-26.95M-25.82%-42.77M-26.79%-42.06M-11.41%-37.06M
Basic earnings per share 23.57%-1.2-95.65%-0.4544.68%-0.2643.48%-0.2643.90%-0.2320.30%-1.5754.90%-0.230.00%-0.472.13%-0.4622.64%-0.41
Diluted earnings per share 23.57%-1.2-95.65%-0.4544.68%-0.2643.48%-0.2643.90%-0.2320.30%-1.5754.90%-0.230.00%-0.472.13%-0.4622.64%-0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg